DAO and schizophrenia: In the light of multiple scientific reports assessing and supporting the hypothesis of DAO alteration as a neurobiological hallmark of schizophrenia, novel chemical compounds targeting and suppressing the oxidase activity have been developed to ameliorate psychotic symptoms (Table 2).